home
 
 
Assay development

A good and robust assay is essential for any process development. areta is able to offer set up of new specific assay for your target molecules or cell line. areta works directly with the customer to define its needs and to identify the right assay format, which enables to design and develop the optimal assay, all the right parameters, thoroughly documented, reproducible and ready for transfer to a GMP/GLP facility. areta develops customized cell-based assays, isolating target screening assays and enzyme assays to meet customer’s needs. Our immune assays services include: recombinant antigen production and purification, antibody production, immune-assay development, and validation.

Cell based tests

In cell-based tests cells are considered to be the basic building blocks of living organisms and can provide data that cannot be obtained from animal or humans models.

areta is able to develop test that relate study and description of many cell functions (cytotoxicity, transport and modulation of cellular components and drugs) for use in the screening for new drugs or as self standing tool.

ELISA

ELISA test

areta has an long experience in the development of several types of ELISA tests (sandwich, competitive, direct, indirect) used in diagnostics or drug surveillance or monitoring. The company’s core activities goes from the set up of a range of different ELISA assays to the validation (detection limit, sensitivity, precision and accuracy) of these tests in appropriate matrices (biological fluids like blood, urine etc., and not) that can be applied in different fields.

 

 
 
 

areta international S.r.l | via R. Lepetit, 34 | 21040 Gerenzano (VA) Italy
Tel: +39 02 96474804 | Fax: +39 02 96474800 | P.iva: 12914940155 | Share capital € 709.249,00